AZIN2 and neoplasm: When we stratified CRC according to stage, high AZIN2 expression was a sign of unfavorable prognosis in Dukes C (Stage III) CRC (p = 0.014); 5-years DSS for patients with high AZIN2 tumor expression was 52.4% (95 CI 41.4–63.3) compared to 67.5% (95% CI 57.5–77.5) for those with low expression.